Genenta Science S.p.A GNTA
NASDAQ GNTA
$1.26 +0.07 (+5.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genenta Science S.p.A (GNTA) Assets Average (2021 - 2025)

Genenta Science S.p.A (GNTA) posted Assets Average of $30.8 million for Q4 2025, up 52.88% sequentially from $20.1 million in Q2 2025, and up 69.38% YoY from $18.2 million in Q4 2024.

Genenta Science S.p.A (GNTA) Assets Average (2021 - 2025) Analysis & Trends

Genenta Science S.p.A has reported Assets Average for 5 years, with the latest figure at $30.8 million in Q4 2025.

  • Quarterly Assets Average rose 69.38% year-over-year to $30.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.8 million (up 69.38% YoY) and the FY2025 annual result came in at $26.5 million, up 32.79% from the prior year.
  • Assets Average improved to $30.8 million in Q4 2025 per GNTA's latest filing, from $20.1 million in the prior quarter.
  • Over five years, Assets Average peaked at $43.3 million in Q2 2022 and troughed at $18.2 million in Q4 2024.
  • A 5-year average of $29.3 million and a median of $30.8 million in 2025 frame the typical range for Assets Average.
  • The sharpest annual moves came in 2024 and 2025: Assets Average tumbled 31.66% in 2024, then soared 69.38% in 2025.
  • Over 5 years, Assets Average stood at $33.3 million in 2021, then climbed by 12.45% to $37.5 million in 2022, then fell by 29.1% to $26.6 million in 2023, then sank by 31.66% to $18.2 million in 2024, then jumped by 69.38% to $30.8 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods registered $30.8 million, $20.1 million, and $18.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.22 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 8.86 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.34 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.27 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.09 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 Genenta Science S.p.A 25.03 Mn -34.07 Mn - 30.76 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 30.76 Mn
Jun 30, 2025 20.12 Mn
Dec 31, 2024 18.16 Mn
Jun 30, 2024 22.26 Mn
Dec 31, 2023 26.57 Mn
Jun 30, 2023 31.61 Mn
Dec 31, 2022 37.48 Mn
Jun 30, 2022 43.32 Mn
Dec 31, 2021 33.33 Mn